搜索
10X Genomics Inc
TXG添加自选
35.730USD
+1.130+3.27%
收盘 06/25, 16:00（美东）报价延迟15分钟
4.54B总市值
亏损市盈率 TTM
查看详细走势图
TradingKey 图表盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+3.27%
5天
+2.81%
1月
+50.89%
6月
+114.08%
今年开始到现在
+119.07%
1年
+206.43%
关键数据
34.660今开
36.880最高
2.95M成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
2.31%换手率
34.600昨收
34.610最低
78.50M成交额
亏损市盈率静
5.73市净率
0.00%股息率 TTM
-2.36%ROA
28.17052周最高
0.80量比
-182.63M净利润
127.69M总股本
-0.1738每股收益TTM
2.11Beta
-2.98%ROE
8.81052周最低
6.56%振幅
70.39%毛利率
4.54B总市值
8.82回报/风险
4.04%风险率
TradingKey 10X Genomics Inc股票评分
单位: USD 更新时间: 2026-06-25操作建议
10X Genomics Inc当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在医疗设备与耗材行业排名39/203位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价27.62。中期看，股价处于上升通道。近一个月，市场表现很强，技术面和基本面综合得分较高，很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
10X Genomics Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
10X Genomics Inc亮点
亮点风险
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
分析师目标
根据
16
位分析师
买入
评级
27.615
目标均价
-13.35%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
10X Genomics Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
10X Genomics Inc简介
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
公司代码TXG
公司10X Genomics Inc
CEOSaxonov (Serge Wilson)
网址https://www.10xgenomics.com/
相关品种
+2.48%
+2.79%
+3.08%
-0.53%
+2.39%
+2.80%
+0.84%
+0.51%
-0.20%
+0.93%
+0.93%
-0.57%
+0.87%
+0.11%
+4.77%
+3.92%
+1.05%
+2.49%
+2.97%
+0.30%热门品种
常见问题
10X Genomics Inc(TXG)的当前股价是多少？
10X Genomics Inc(TXG)的当前股价是 35.73。
10X Genomics Inc的股票代码是什么？
10X Genomics Inc的股票代码是TXG。
10X Genomics Inc股票的52周最高点是多少？
10X Genomics Inc股票的52周最高点是28.17。
10X Genomics Inc股票的52周最低点是多少？
10X Genomics Inc股票的52周最低点是8.81。
10X Genomics Inc的市值是多少？
10X Genomics Inc的市值是4.56B。
现在10X Genomics Inc(TXG)的股票是买入、持有还是卖出？
根据分析师评级，10X Genomics Inc(TXG)的总体评级为买入，目标价格为27.62。
10X Genomics Inc(TXG)股票的每股收益（EPS TTM）是多少
10X Genomics Inc(TXG)股票的每股收益（EPS TTM）是-0.35。
